FDA Says No to Vioxx Successor Critics have questioned adequacy of safety trials for Arcoxia
By E.J. MundellHealthDay Reporter
This article is older than one year and is no longer available.
Last Updated: April 27, 2007
Copyright © 2007 ScoutNews, LLC. All rights reserved.
